Orkun Ozhelvaci
Mainz, RP 55131, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity.
Journal: Cell reports
Published: March 17, 2023
Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice.
Journal: Science immunology
Published: November 15, 2022
Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5.
Journal: Science immunology
Published: September 20, 2022
Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial.
Journal: The Lancet regional health. Western Pacific
Published: September 19, 2022
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes.
Journal: Science immunology
Published: June 02, 2022
Immune Persistence and Safety After SARS-CoV-2 BNT162b1 mRNA Vaccination in Chinese Adults: A Randomized, Placebo-Controlled, Double-Blind Phase 1 Trial.
Journal: Advances in therapy
Published: April 06, 2022
Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera.
Journal: Science (New York, N.Y.)
Published: January 18, 2022
Evaluation of convenient pretreatment protocols for RNA virus metagenomics in serum and tissue samples.
Journal: Journal of virological methods
Published: January 23, 2015
False-positive results in metagenomic virus discovery: a strong case for follow-up diagnosis.
Journal: Transboundary and emerging diseases
Published: March 11, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026